Ki A Goosens, PhD
- ASSOCIATE PROFESSOR | Psychiatry
Research Topics:
Adipose, Biomedical Sciences, Brain, Cognitive Neuroscience, Diabetes, Electrophysiology, Endocrinology, Gene Regulation, Gene Therapy, Hippocampus, Hormones, Memory, Metabolism, Neurobiology, Neuropeptides, Neuroscience, Psychiatry, Stress, Systems Biology, Systems Neuroscience, Translational Research, TraumaDr. Goosens studies chronic stress and its impact on the brain and body. Stress responses can be adaptive, but when experienced repeatedly or over a protracted period of time, stress is strongly associated with multiple types of disease, including posttraumatic stress disorder (PTSD), depression, obesity, and diabetes. Her current lines of research focus on 1) Identifying novel circuit mechanisms for associative emotional memory formation and their dysregulation by stress; 2) Understanding the mechanisms by which emotional memory encoding is modulated; and 3) Studies to identify and characterize the endocrine factors that underlie stress-induced vulnerability in rodent models of post-traumatic stress disorder (PTSD), Major Depressive Disorder (MDD), and obesity, and also understand how these factors regulate normal function in the brain and periphery.
The lab website is located at: https://labs.icahn.mssm.edu/goosenslab/
Multi-Disciplinary Training Area
Neuroscience [NEU]Education
BA, University of Virginia
MS, University of Michigan
PhD, University of Michigan
None, Stanford University
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Goosens did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.